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Background: Recent reports have suggested that laparoendoscopic single site (LESS) surgery is technically feasible.
The aim of this study was to describe our initial experience with LESS adrenalectomy for benign adrenal tumors,
focusing the attention about cosmetic satisfaction and reduction of postoperative pain.
Methods: Medical records of consecutive patients undergoing LESS adrenalectomy were analyzed. All procedures
were performed through a single multichannel port. Demographic and operative data were assessed. A visual
analog scale (VAS) was used with a 10-point scale for an objective assessment of incisional pain and incisional
cosmesis.
Results: Between January 2010 and July 2012, 14 consecutive patients with benign adrenal tumors underwent LESS
adrenalectomies. Of the planned LESS adrenalectomies, 12 (86%) were completed with a single-port, whereas two
required an additional port placement. Mean operating time was 128.1 ± 31.5 min and mean blood loss 10.5 ±
12.1 ml. Mean pain scores using the VAS on postoperative days 1, 3, and 14 were 2.3, 1.0, and 0.3 points,
respectively. The rate of analgesic use was also lower within 12 hours after surgery (14%). The patient was highly
satisfied with the single small wound procedure, and mean cosmesis scores of postoperative days 3 and 14 were
9.4 and 9.8 points, respectively. The postoperative course was uneventful with no morbidity within one month of
follow-up.
Conclusions: LESS adrenalectomy is a safe and technically feasible procedure for patients with benign adrenal
tumors, and offers cosmetic benefit and the potential for postoperative pain reduction. However, surgeons with
lack of experience as LESS surgery should be comprehended that the assistance of the needlescopic instrument
does not compromise the cosmetic outcomes for difficult cases and the obese patients may not always be suitable
candidates for pure LESS technique.
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A conventional multiport laparoscopic adrenalectomy
(MPLA) using three or four ports is the gold standard op-
erative treatment for benign adrenal tumors [1-3]. The
advantages of MPLA include decreased pain, shorter hos-
pital stay, and an earlier return to normal activity. Recently,
a laparoendoscopic single site (LESS) surgery was devel-
oped as an extension of the standard laparoscopic minim-
ally invasive procedures. LESS surgery has the potential to
provide patients with improved cosmesis and decreased
pain; as such, it satisfies a growing demand for less invasive
surgical procedures [4,5]. Since the initial report of laparo-
scopic adrenalectomy using a single-incision [6], several
investigators have demonstrated the technical feasibility of
a variety of LESS procedures for adrenal tumors [7,8].
LESS surgery obviates the need to externally space ports
for triangulation, thus allowing for the creation of a small,
solitary portal of entry into the abdomen. However, we
have previously reported our initial developmental experi-
ences with select LESS procedures [9-13]. The aim of this
study was to describe our initial experience with LESS
adrenalectomy for benign adrenal tumors, focusing the at-
tention about cosmetic satisfaction and reduction of post-
operative pain.Methods
Patients
Data were prospectively entered in an LESS adrenalectomy
database and retrospectively reviewed. Between January
2010 and July 2012, 14 consecutive patients (7 men and 7
women) with benign adrenal tumors underwent LESS ad-
renalectomies at the Iwate Medical University Hospital. All
procedures were performed by a single surgeon. Informed
consent was received from all the patients for the proced-
ure, and the difference between the LESS and the conven-
tional multiport approaches were explained. This study
was approved by the institutional review board at Iwate
Medical University Hospital and conducted in accordance
with Declaration of Helsinki.
As a general principle, indications for LESS adrenalec-
tomy were hormonally active tumors ranging in size up to
5 cm, and non-functioning tumors greater than 3 cm, or





Previous upper abdominal surgery
Disease
BMI, body mass index.suspected adrenocortical carcinoma, invasive pheochromo-
cytoma, or high-risk patients with poor general condition.
A visual analog scale (VAS) was used as an objective
assessment of incisional pain on postoperative days 1, 3,
and 14, and for incisional cosmesis on postoperative
days 3 and 14. The VAS was used to score incisional
pain on a 10-point scale with a range from 0 (no pain)
to 10 (worst possible pain). The VAS was also used to
score cosmesis on a 10-point scale with a range from 0
(worst) to 10 (best). Data are expressed as mean ± stand-
ard deviations (SD).Surgical technique
The patient was placed in the semilateral position. All pro-
cedures were performed through a single multichannel
port. A 2.5 cm incision was made through the umbilical
skin and fascia. The wound protector/sleeve of the
GelPOINT (Applied Medical, CA, USA) was placed. Three
5-mm cannulas were placed through the GelPOINT and
then attached to the wound protector. A 5-mm flexible
laparoscope (Olympus Medical Systems, Tokyo, Japan), a
SILS dissector (Covidien, NewHaven, CT, USA), and a tis-
sue sealing device (EnSeal, Ethicon, Cincinnati, OH, USA)
were the primary tools used in the operation. An anterior
approach, with no mobilization of the right lobe, was used
for the right-sided tumors, while a lateral approach was
used for left-sided tumors. Only the central adrenal vein
was clipped and the small adrenal vessels were divided
using an EnSeal device. For the right-sided adrenal tumor,
the right liver lobe was evaluated using a 2.3 mm percutan-
eous instrument (MiniLap, Stryker, Kalamazoo, MI, USA)
and a small gauze, which provided good visualization of
the operative field surrounding the right adrenal gland. Al-
though MiniLap insertion appears to be scar-less, a needle
instrument can be traumatic for the liver. To avoid a trau-
matic procedure, we used small gauze as cushioning to
evaluate the liver. The overall procedure was similar to the
procedure performed in a conventional anterior approach
using a four-port technique (Figure 1). The adrenal gland
was extracted without a retrieval bag. The umbilical fascia
was closed with a 2-0 Vicryl suture. The skin was closed














Figure 1 Intraoperative view of LESS right adrenalectomy. A: The liver was evaluated using a MiniLap and small gauze. B: The peritoneum
and Gerota’s fascia was incised using an electrocautery. C: Small adrenal vessels were divided using an EnSeal. D: The right main adrenal vein was
clipped and divided. E: The retroperitoneal space was examined for any evidence of bleeding. Arrow indicates right main adrenal vein. AG;
adrenal gland, K; kidney, PM; psoas muscle, IVC; inferior vena cava.
Table 2 Patient demographics
LESS adrenalectomy (n=14)
Age (years) * 51.7 ± 11.6
Sex (Male/Female) 7/7
BMI (kg/m2) * 24.4 ± 3.3
Tumor location (Right/Left) 6/8





*Values are means ± standard deviation.
LESS; laparoendoscopic single site, BMI; body mass index.
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Patient demographics are summarized in Table 2. Mean
age was 51.7 ± 11.6 years. Indications for LESS adrenal-
ectomy were 11 aldosterone-producing adenomas, 2
non-functioning tumors, and 1 patient with Cushing’s
syndrome. Operative outcomes are detailed in Table 3. Of
the planned LESS adrenalectomies, 12 (86%) were com-
pleted with a single-port, whereas two required an add-
itional port placement for patients with body mass indexes
greater than 27 kg/m2. Mean operating time was 128.1 ±
31.5 min and mean blood loss was 10.5 ± 12.1 ml. There
was no difference between the initial 7 cases and the last 7
cases in mean operating time (134.4 min versus 121.9 min,
p=0.477). There were also no other significant differences
between the preoperative characteristics of the patients.
No blood transfusions were required. Mean tumor size
was 21.2 ± 7.0 mm. No patients demonstrated a delay in
initiating oral intake or a regular diet. Mean hospital stay
Table 3 Operative outcomes
LESS adrenalectomy (n=14)
Operating time (min) * 128.1 ± 31.5
Blood loss (ml) * 10.5 ± 12.1
Tumor size (mm) * 21.2 ± 7.0
Resumption of oral intake (days) * 1
Analgesics within 12 h after surgery (n) 2
Length of hospital stay (days) * 3.9 ± 1.0
Conversion to two port surgery 3
Morbidity 0
Mortality 0
*Values are means ± standard deviation.
LESS, laparoendoscopic single site.
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complete at two weeks. The postoperative course was un-
eventful with no morbidity within one month of follow-up.
Mean scores for postoperative incisional pain on postop-
erative days 1, 3, and 14 were 2.3 ± 1.6, 1.0 ± 1.1, and 0.3
± 0.7 points, respectively. The rate of analgesic use
(diclofenac sodium suppository; 50 mg) was also lower
within 12 hours after surgery (14%). According to their
self-assessments, mean cosmesis scores on postoperative
days 3 and 14 were 9.4 ± 0.7 and 9.8 ± 0.3 points, respect-
ively. The rates of best cosmetic satisfaction (VAS score of
10) at 3 and 14 days were 57% and 79%, respectively. The
patient has had an excellent cosmetic result on postopera-
tive follow-up (Figure 2).
A limited cost analysis was performed on the series of
patients undergoing SPLA. LESS adrenalectomy wasA B
Figure 2 Cosmetic results. A: Postoperative photograph of patient’s abdo
epigastric region points to the puncture site from the 2.3 mm needlescopi
3 years after LESS left adrenalectomy.associated with 18% lower mean operative charges com-
pared with the standard MPLA (¥147,000 vs ¥180,000).
Discussion
Conventional multiport laparoscopic surgery is the gold
standard operative treatment for a variety of diseases.
Generally, the goal has been to minimize the invasive-
ness of this procedure by reducing the number or size of
the operating ports. Recently, LESS surgery was developed
as an extension of standard laparoscopic minimally inva-
sive procedures. The potential for decreased pain, faster
recovery, and improved cosmesis has surgeons, their pa-
tients, and the industry interested in pushing the tech-
nique forward. In 2008, Castellucci et al. [6] reported the
first LESS adrenalectomy in a 63-year-old female patient
with a 4.5-cm left adrenal incidentaloma. They used a 3-
port technique, introduced through a 2-cm supraumbilical
incision and successfully removed a pheochromocytoma.
However, LESS adrenalectomy is still limited by the surgi-
cal team’s adrenal and laparoscopic experience [6-8,12].
Since March 2009, we have been using LESS chole-
cystectomies in selected patients with benign gallbladder
diseases. Additionally, our team has recently performed
successful advanced LESS procedures, such as gastrec-
tomy, colectomy, splenectomy, Heller-Dor procedure,
and Nissen fundoplication [9-13]. At our institution,
LESS adrenalectomy was introduced after more than
100 MPLAs were conducted. Since our first description
in 2010 [12], we have performed LESS adrenalectomies
on consecutive patients with benign adrenal tumors. In
a LESS left adrenalectomy, as in conventional MPLA,
the spleen is mobilized which provides a good operative
field surrounding the left adrenal gland. The applicabilitymen at 8 months after LESS right adrenalectomy. Black arrow in the
c instrument. B: Postoperative photograph of patient’s abdomen at
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widespread use, however, due to its technical challenges.
The most important technical challenge for LESS right
adrenalectomy is providing a good operative field sur-
rounding the right-sided tumors. However, an elevation
of the right liver lobe using a percutaneous instrument
provided good visualization of the operative field, which
reproduced a result similar to that observed in MPLA.
The assistance of the needlescopic instrument does not
compromise the cosmetic outcomes; this fact is consid-
ered to be one of the main advantages of LESS
adrenalectomy over MPLA. An additional 5-mm port
was required in two patients with body mass indexes
greater than 27 kg/m2. Good laparoscopic skills and
careful patient selection are essential; additional ports
should be considered to help with liver retraction.
Two matched-control studies have reported that pa-
tients undergoing LESS adrenalectomy had significantly
lower pain scores or required significantly less analgesia
[7,14]. Jeong et al. [7] reported the first matched case–
control study to demonstrate the technical feasibility of
LESS adrenalectomy, compared with conventional MPLA,
in the removal of a benign adenoma. Nine patients under-
going LESS adrenalectomies were compared with 17 pa-
tients undergoing conventional MPLA. No significant
differences were found between the groups in terms of
mean operating time, blood loss, or postoperative hos-
pitalization. However, the degree of postoperative pain
was significantly lower in the LESS adrenalectomy group
than in the MPLA group. Our study also demonstrates
that the postoperative VAS scores for incisional pain were
lower. However, evaluation of postoperative cosmetic out-
comes is a challenge, due to the absence of a reliable ob-
jective scale. The combination of multiple contributing
factors, potential observer bias, and variations in patients’
expectations contributes to difficulties in assessing cos-
metic outcomes [15]. In our series, we observed that
patients scored the single-wound technique significantly
better with regard to cosmetic appearance. However, oper-
ating surgeons should consider carefully which patients
would be ideal candidates for initial LESS adrenalectomies.Conclusions
LESS adrenalectomy is a safe and technically feasible pro-
cedure for patients with benign adrenal tumors, and offers
cosmetic benefit and the potential for postoperative pain re-
duction. However, surgeons with lack of experience as LESS
surgery should be comprehended that the assistance of the
needlescopic instrument does not compromise the cosmetic
outcomes for difficult cases and the obese patients may not
always be suitable candidates for pure LESS technique.
Further studies are necessary to clearly identify the risks
and benefits of this new approach to the adrenalectomy.Consent
Written informed consent was obtained from the patient
for publication of this report and any accompanying im-
ages. A copy of the written consent is available for review
by the Editor-in-Chief of this journal.
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